Dana C.

Dana C. has extensive experience in oligonucleotide chemistry, holding the position of Senior Scientist at Aligos Therapeutics since May 2019. Responsibilities at Aligos Therapeutics include scale-up and process development, as well as previous roles as Scientist II and Scientist I in Process Development and Research & Development, respectively. Prior to this, Dana C. worked as a Scientist in Research & Development at LGC, Biosearch Technologies from March 2017 to April 2019, focusing on oligonucleotide chemistry, R&D, and scale-up activities.